183 related articles for article (PubMed ID: 36921674)
1. Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.
Chen J; Liu K; Luo Y; Kang M; Wang J; Chen G; Qi J; Wu W; Wang B; Han Y; Shi L; Wang K; Han X; Ma X; Liu W; Ding Y; Wang L; Liang H; Wang L; Chen J
Gastroenterology; 2023 Jul; 165(1):88-103. PubMed ID: 36921674
[TBL] [Abstract][Full Text] [Related]
2. miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression.
Yan C; Yu J; Kang W; Liu Y; Ma Z; Zhou L
Biochem Biophys Res Commun; 2016 Jan; 470(1):68-74. PubMed ID: 26742429
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.
Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J
Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691
[TBL] [Abstract][Full Text] [Related]
5. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction.
Chen J; Sun D; Chu H; Gong Z; Zhang C; Gong B; Li Y; Li N; Jiang L
Oncol Rep; 2015 Jun; 33(6):2963-71. PubMed ID: 25964059
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
7. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J
Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266
[TBL] [Abstract][Full Text] [Related]
8. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic and clinicopathologic features of early gastric signet ring cell carcinoma ≤20 mm: a retrospective observational study.
Xu J; Zhu J; Lin L; Li Z; Gu F; Wang F; Zhai H
Scand J Gastroenterol; 2023 Jan; 58(1):38-44. PubMed ID: 35850581
[TBL] [Abstract][Full Text] [Related]
10. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing.
Jiang H; Yu D; Yang P; Guo R; Kong M; Gao Y; Yu X; Lu X; Fan X
Clin Transl Med; 2022 Feb; 12(2):e730. PubMed ID: 35184420
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
14. Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis.
Zhao ZT; Li Y; Yuan HY; Ma FH; Song YM; Tian YT
World J Clin Cases; 2020 Feb; 8(4):658-669. PubMed ID: 32149050
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Profiling of Gastric Signet Ring Cell Carcinoma Tissues Reveals Characteristic Changes of the Complement Cascade Pathway.
Fan Y; Bai B; Liang Y; Ren Y; Liu Y; Zhou F; Lou X; Zi J; Hou G; Chen F; Zhao Q; Liu S
Mol Cell Proteomics; 2021; 20():100068. PubMed ID: 33676000
[TBL] [Abstract][Full Text] [Related]
16. CD226 identifies functional CD8
Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
[TBL] [Abstract][Full Text] [Related]
17. Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor Progression.
Wei Y; Zhang J; Fan X; Zheng Z; Jiang X; Chen D; Lu Y; Li Y; Wang M; Hu M; Du Q; Yang L; Li H; Xiao Y; Li Y; Jin J; Wang D; Yuan X; Li Q
Front Immunol; 2022; 13():935552. PubMed ID: 35874784
[TBL] [Abstract][Full Text] [Related]
18. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
[TBL] [Abstract][Full Text] [Related]
19. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
[TBL] [Abstract][Full Text] [Related]
20. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
